Association of serum AACT levels and AACT signal polymorphism with late-onset Alzheimer's disease in Northern Ireland

International Journal of Geriatric Psychiatry

Volumn 15, Issue 3, 2000, Pages 260-266

  McIlroy, S P ^a   Vahidassr, M D ^a   Savage, D A ^a   Lloyd, F ^b   Patterson, C C ^a   Lawson, J T ^b   Passmore, A P ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

1 Antichymotrypsin; Alzheimer's disease; APOE; Cognitive decline

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; AMYLOID; APOLIPOPROTEIN E4; DNA;

AGED; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PROTEIN POLYMORPHISM; RISK FACTOR; UNITED KINGDOM;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALLELES; ALPHA 1-ANTICHYMOTRYPSIN; ALZHEIMER DISEASE; APOLIPOPROTEINS E; FEMALE; GENOTYPE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; NORTHERN IRELAND; POLYMORPHISM, GENETIC;

EID: 0034032825     PISSN: 08856230     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1166(200003)15:3<260::AID-GPS109>3.0.CO;2-M     Document Type: Article

References (25)

1. Abraham, C. R., Shirahama, T. and Potter, H. (1990) Alpha 1-antichymotrypsin is associated solely with amyloid deposits containing the beta-protein. Neurobiol. Aging 11, 123-129.
2. Altstiel, L. D., Lawlor, K. L., Mohs, R., Schmeidler, J., Dalton, A., Mehta, P. and Davis, K. (1995) Elevated alpha 1-antichymotrypsin serum levels in a subset of non-demented first degree relatives of Alzheimer's disease patients. Dementia 6, 17-20.
3. Crooks, R., Hardy, J. and Duff, K. (1994) Single-day apolipoprotein E genotyping. J. Neurosci. Methods 53, 125-127.
4. Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975) 'Mini-Mental State' a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189-198.
5. Gabriel, S. M., Marin, D. B., Aisen, P. S., Lantz, M., Altstiel, L. D., Davis, K. L. and Mohs, R. C. (1998) Association of elevated a 1-antichymotrypsin with cognitive impairment in a prospective study of the very old. Am. J. Psychiat. 155, 698-700.
6. Haines, J. L., Prichard, M. L., Saunders, A. M., Schildkraut, J. M., Growdon, J. H., Gaskell, P. C., Farrer, L. A., Auerbach, S. A., Gusella, J. F., Locke, P. A., Rosi, B. L., Yamoka, L., Small, G. W., Conneally, P. M., Roses, A. D. and Pericak-Vance, M. A. (1996) No genetic effect of α1-antichymotrypsin in Alzheimer's disease. Genomics 33, 53-56.
7. Harigaya, Y., Shoji, M., Nakamura, T., Matsubara, E., Hosoda, K. and Hirai, S. (1995) Alpha 1-antichymotrypsin level in cerebrospinal fluid is closely associated with late onset Alzheimer's disease. Intern. Med. 34, 481-484.
8. Hinds, T. R., Kukull, W. A., Van Belle, G., Schellenberg, G. D., Villacres, E. C. and Larson, E. B. (1994) Relationship between serum α1-antichymotrypsin and Alzheimer's disease. Neurobiol. Aging 15, 21-27.
9. Janciauskiene, S., Rubin, S., Lukacs, C. M. and Wright, H. T. (1998) Alzheimer's peptide Abeta 1-42 binds to two beta-sheets of alpha 1-antichymotrypsin and transforms it from inhibitor to substrate. J. Biol. Chem. 273, 28360-28364.
10. Kemboh, M. I., Sanghera, D. K., Ferrell, R. E. and DeKosky, S. T. (1995) APOE*4-associated Alzheimer's disease risk is modified by α1-antichymotrypsin polymorphism. Nature Genet. 10, 486-488.
11. Licastro, F., Morini, M. C., Polazzi, E. and Davis, L. J. (1995) Increased serum alpha 1-antichymotrypsin in patients with probable Alzheimer's disease: an acute phase reactant without the peripheral acute phase response. J. Neuroimmunol. 57, 71-75.
12. Ma, J., Yee, A., Brewer, B., Das, S. and Potter, H. (1994) Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of β-amyloid into filaments. Nature 372, 92-94.
13. Mancini, G., Carbonara, A. O. and Heremans, J. F. (1965) Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochem. 2, 235-254.
14. Matsubara, E., Hirai, S., Amari, M., Shoji, M., Yamaguchi, H., Okamoto, K., Ishiguro, K., Harigaya, Y. and Wakabayashi, K. (1990) Alpha 1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia. Ann. Neurol. 28, 561-567.
15. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E. M. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 24, 939-944.
16. Miller, S. A., Dykes, D. D. and Polesky, H. F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 13, 1215.
17. Morgan, K., Morgan, L., Carpenter, K., Lowe, J., Lam, L., Cave, S., Xuereb, J., Wischik, C., Harrington, C. and Kalsheker, N. A. (1997) Microsatellite polymorphism of the alpha-1-antichymotrypsin gene locus associated with sporadic Alzheimer's disease. Hum. Genet. 99, 27-31.
18. Pirttila, T., Mehta, P. D., Frey, H. and Wisniewski, H. M. (1994) Alpha 1-antichymotrypsin and IL-1 beta are not increased in CSF or serum in Alzheimer's disease. Neurobiol. Aging 15, 313-317.
19. Schmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M. Joo, S. H., Pericak-Vance, M. A., Goldgaber, D. and Roses, A. D. (1993) Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proc. Natl. Acad. Sci. USA 90, 9649-9653.
20. Selkoe, D. J. (1996) Amyloid B-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271, 18295-18298.
21. Talbot, C., Houlden, H., Craddock, N., Crook, R., Hutton, M., Lendon, C., Prihar, G., Morris, J. C., Hardy, J. and Goate, A. (1996) Polymorphism in AACT gene may lower age of onset of Alzheimer's disease. Neuroreport 7, 534-536.
22. Tysoe, C., Galinsky, D., Robinson, D., Brayne, C. E., Easton, D. E., Huppert, F. A., Dening, T., Paykel, E. S. and Rubinsztein, D. C. (1997) Analysis of alpha-1 antichymotrypsin, presinilin-1, angiotensin-converting enzyme and methelene tetrahydrofolate reductase loci as candidates for dementia. Am. J. Med. Genet. 74, 207-212.
23. Wasco, W. and Tanzi, R. E. (1997) Etiological clues from gene defects causing early onset familial Alzheimer's disease. In Molecular Mechanisms of Dementia (W. Wasco and R. E. Tanzi, Eds). Humana Press, Totowa.
24. 1-antichymotrypsin as a risk modifier for late-onset Alzheimer's disease in Japanese apolipoprotein E ε4 carriers. Ann. Neurol. 42, 115-117.
25. Zchocke, J., Mallory, J. P., Eiken, H. G. and Nevin, N. C. (1997) Phenylketonuria and the peoples of Northern Ireland. Hum. Genet. 100, 189-194.